Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
7733 On Other Exchanges
Symbol
Exchange
7733 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

olympus corp (7733) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OLYMPUS CORP (7733)

Related News

No related news articles were found.

olympus corp (7733) Related Businessweek News

View More BusinessWeek News

olympus corp (7733) Details

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates in four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others Business. The Medical Business segment provides endoscopy systems comprising videoscopes, video processors, light sources, and liquid crystal display panels; peripheral equipment, such as image recording devices, endoscope cleaning systems, sterilization systems, etc.; surgical video endoscopy systems, peripheral devices for endoscopic surgery, electrosurgical knives, etc.; and endoscopic devices for various diagnostic and treatment procedures, including biopsy forceps, high-frequency polypectomy snares, grasping forceps, stone retrieval and lithotriptor baskets, hemostasis accessories, etc. The Scientific Solutions Business segment offers upright and polarizing microscopes, inverted microscopes, laser confocal microscopes, box-type fluorescence imaging devices, stereo microscopes, fluorescence macro microscopes, microscope digital cameras, imaging software, bio-imaging systems, and virtual slide systems; and metallurgical microscopes, semiconductor inspection microscopes, laser and measuring microscopes, microscopic 3D measurement systems, industrial videoscopes and fiberscopes, industrial rigid scopes, ultrasonic flaw detectors, eddy current flaw detectors, phased array flaw detectors, X-ray diffraction analyzers, and peripheral equipment. The Imaging Business segment offers digital single-lens cameras, compact digital cameras and related products, digital camera lens barrels, and optical components, as well as IC recorders and binoculars. The Others Business segment manufactures biomedical materials, as well as conducts system development and other business activities. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

Founded in 1919

olympus corp (7733) Top Compensated Officers

President and Representative Director
Total Annual Compensation: ¥100.0M
Compensation as of Fiscal Year 2014.

olympus corp (7733) Key Developments

Olympus to Build Medical Training Center

Olympus it will build a new medical training center in Songdo, Incheon, due for completion in February 2017. The Olympus Korea Training and Education Center aims to offer diverse training programs for health care professionals on the safe and effective use of the company's innovative medical and surgical products, including its market No. 1 endoscopy equipment. With a budget of $33.2 million, the new center is the sixth of its kind globally and the second-largest in terms of size. Olympus Korea signed an agreement with the Incheon Free Economic Zone Authority for what would become the large amount of investment made by an overseas medical equipment company in Korea. The four-story building will be located on a 5,0000-square-meter site within an industrial complex in Songdo, which is also home to a slew of local bio companies such as Samsung Biologics and Celtrion. The center, consisting of laboratories, an auditorium, a showroom for new products and an after-sales center, are expected to create some 70 new jobs and attract more than 10,000 visitors annually.

Olympus Corporation Announces Consolidated Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2016

Olympus Corporation announced consolidated earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, the company announced net sales of JPY 214,656 million against JPY 199,612 million a year ago. Operating income was JPY 28,894 million against JPY 23,549 million a year ago. Loss before income taxes and minority interests was JPY 31,816 million against income before income taxes and minority interests of JPY 1,294 million a year ago. Net loss was JPY 40,663 million against net income of JPY 7,784 million a year ago. Capital expenditure was JPY 19,957 million compared to JPY 11,554 million for the same period a year ago. EBITDA was JPY 42,696 million compared to JPY 36,716 million for the same period a year ago. Cash flow from operating activities was JPY 31,052 million compared to JPY 28,583 million for the same period a year ago. Free cash flow was JPY 12,952 million compared to JPY 22,210 million for the same period a year ago. For the full year, the company announced net sales of JPY 764,671 million against JPY 713,286 million a year ago. Operating income was JPY 90,962 million against JPY 73,445 million a year ago. Income before income taxes and minority interests was JPY 8,934 million against JPY 16,425 million a year ago. Net loss was JPY 8,737 million against net income of JPY 13,627 million a year ago. Capital expenditure was JPY 47,743 million compared to JPY 37,810 million for the same period a year ago. EBITDA was JPY 141,602 million compared to JPY 119,752 million for the same period a year ago. Cash flow from operating activities was JPY 66,811 million compared to JPY 72,388 million for the same period a year ago. Free cash flow was JPY 27,199 million compared to JPY 52,115 million for the same period a year ago. The company provided consolidated earnings guidance for the full year ending March 31, 2016. For the full year, the company expects to report net sales of JPY 810,000 million, gross profit of JPY 533,400 million, operating income of JPY 100,000 million, ordinary income of JPY 86,000 million, income before income taxes and minority interests of JPY 86,000 million, total income taxes of JPY 30,000 million and net income of JPY 56,000 million. Capital expenditure expected to be JPY 69,000 million and depreciation and amortization expected to be JPY 43,000 million. EBITDA is expected to be JPY 152,200 million or margin of 18.8%.

Olympus Corporation Announces Year End Dividend for the Fiscal Year Ended March 31, 2015 Payable on June 29, 2015; Expects to Pay Year End Dividend for the Fiscal Year Ended March 31, 2016

Olympus Corporation announced a year end dividend of ¥10 per share for the fiscal year ended March 31, 2015 compared to nil dividend a year ago. The company scheduled to commence dividend payments on June 29, 2015. Record date is March 31, 2015. The company expects to pay year end dividend of ¥17 per share for the fiscal year ended March 31, 2016.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
7733:JP ¥4,170.00 JPY 0.00

7733 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AMETEK Inc $54.75 USD -0.20
Avery Dennison Corp $62.58 USD +0.62
CR Bard Inc $171.95 USD -0.43
Smith & Nephew PLC 1,134 GBp -6.00
Terumo Corp ¥2,860 JPY +1.00
View Industry Companies
 

Industry Analysis

7733

Industry Average

Valuation 7733 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book 4.0x
Price/Cash Flow 46.3x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OLYMPUS CORP, please visit www.olympus-global.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.